ALEXION PHARMACEUTICALS, INC. Insider Trading for September 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALEXION PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ALEXION PHARMACEUTICALS, INC. for September 2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 26 2014 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Chief Global O ... | Sell | S | 159.50 | 76 | 12,122 | 106,868 | 106.9 K to 106.9 K (-0.07 %) |
Sep 26 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 166.72 | 4,338 | 723,231 | 948,886 | 953.2 K to 948.9 K (-0.46 %) |
Sep 26 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 165.43 | 14,837 | 2,454,485 | 953,224 | 968.1 K to 953.2 K (-1.53 %) |
Sep 26 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 164.83 | 40,825 | 6,729,185 | 968,061 | 1 M to 968.1 K (-4.05 %) |
Sep 18 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 17.65 | 32,047 | 565,630 | 0 | |
Sep 18 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 161.45 | 12,388 | 2,000,043 | 1,008,886 | 1 M to 1 M (-1.21 %) |
Sep 18 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 160.53 | 19,169 | 3,077,200 | 1,021,274 | 1 M to 1 M (-1.84 %) |
Sep 18 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 159.87 | 12,878 | 2,058,806 | 1,040,443 | 1.1 M to 1 M (-1.22 %) |
Sep 18 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 17.65 | 32,047 | 565,630 | 1,053,321 | 1 M to 1.1 M (+3.14 %) |
Sep 12 2014 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Option Exercise | A | 164.16 | 25,000 | 4,104,000 | 25,000 | |
Sep 12 2014 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
Sep 12 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 17.98 | 12,199 | 219,338 | 130,000 | |
Sep 12 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 165.38 | 12,199 | 2,017,471 | 1,021,274 | 1 M to 1 M (-1.18 %) |
Sep 12 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Grant | A | 17.98 | 12,199 | 219,338 | 1,033,473 | 1 M to 1 M (+1.19 %) |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 17.98 | 21,214 | 381,428 | 142,199 | |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 17.98 | 90,919 | 1,634,724 | 163,413 | |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 17.98 | 85,668 | 1,540,311 | 254,332 | |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 165.11 | 21,214 | 3,502,644 | 1,021,274 | 1 M to 1 M (-2.03 %) |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 17.98 | 21,214 | 381,428 | 1,042,488 | 1 M to 1 M (+2.08 %) |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 165.39 | 3,718 | 614,920 | 1,021,274 | 1 M to 1 M (-0.36 %) |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 164.86 | 25,165 | 4,148,702 | 1,024,992 | 1.1 M to 1 M (-2.40 %) |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 163.81 | 23,939 | 3,921,448 | 1,050,157 | 1.1 M to 1.1 M (-2.23 %) |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 162.82 | 25,274 | 4,115,113 | 1,074,096 | 1.1 M to 1.1 M (-2.30 %) |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 161.91 | 12,823 | 2,076,172 | 1,099,370 | 1.1 M to 1.1 M (-1.15 %) |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 17.98 | 90,919 | 1,634,724 | 1,112,193 | 1 M to 1.1 M (+8.90 %) |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 170.35 | 9,299 | 1,584,085 | 1,021,274 | 1 M to 1 M (-0.90 %) |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 169.54 | 12,700 | 2,153,158 | 1,030,573 | 1 M to 1 M (-1.22 %) |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 168.17 | 4,029 | 677,557 | 1,043,273 | 1 M to 1 M (-0.38 %) |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 167.23 | 14,740 | 2,464,970 | 1,047,302 | 1.1 M to 1 M (-1.39 %) |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 166.31 | 20,392 | 3,391,394 | 1,062,042 | 1.1 M to 1.1 M (-1.88 %) |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 165.26 | 24,508 | 4,050,192 | 1,082,434 | 1.1 M to 1.1 M (-2.21 %) |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 17.98 | 85,668 | 1,540,311 | 1,106,942 | 1 M to 1.1 M (+8.39 %) |
Sep 04 2014 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | SVP, Chief HR Offic ... | Sell | S | 169.46 | 304 | 51,516 | 16,272 | 16.6 K to 16.3 K (-1.83 %) |